The COVID-19 pandemic appeared in China on 31 December 2019, and it spread fast in every part of the world, especially, in European countries like Italy and France, consequently, the search for a resolution to this pandemic in all these countries should also be taken into account.
The current study aimed to evaluate the efficiency of European Countries based on the case fatality rate of COVID-19, The sample spans 30 countries, the analysis made recourse to Data Envelopment Analysis, the study used population density and total cases as input indicators and case fatality rate (CFR) as output indicator. The results demonstrate that of 30 countries analyzed, only 6 proved efficient. The average efficiency of inefficient countries is 0.372. Greece achieved the least efficiency rate compared to other European countries. The highest case fatality rate has been registered in Belgium, the lowest case fatality rate has been registered in Monaco. We engaged in a year-long battle with a virus that has destroyed this world, that has caused pain, loss, and frustration and that has cost so many lives.
This article attempts to examine the networked business as a partnership strategy in a very complicated competitive context. At first, we focus on the design, characteristics and the different strategic objectives undertaken by the forms of cooperation. The second part of the article is devoted to determine the decisive factors such as trust and transparency as well as shared interest adopted by the managers to build a sustainable partnership network.
يهدف المقال إلى دراسة العوامل الموقعية وعلاقتها باستقطاب الاستثمار الأجنبي المباشر في ظل العولمة والانفتاح، وذلك باختيار صناعة البرمجيات الهندية كنموذج للدراسة
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.